Conjugates of nucleoside analogs with lactosaminated human albumin to selectively increase the drug levels in liver blood: Requirements for a regional chemotherapy

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 2, 2002, Pages 638-642

  Stefano, Giuseppina Di ^a,b   Lanza, Marcella ^a,b   Busi, Corrado ^a,b   Barbieri, Luigi ^a,b   Fiume, Luigi ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Dipartimento di Patologia Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; FLOXURIDINE; GALACTOSE; GEMCITABINE; HUMAN ALBUMIN; NUCLEOSIDE DERIVATIVE; VIDARABINE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CHEMOTHERAPY; CONJUGATE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG LIVER LEVEL; DRUG UPTAKE; LIVER CELL; LIVER METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DEOXYCYTIDINE; DRUG DELIVERY SYSTEMS; FLOXURIDINE; LIVER; MALE; MODELS, ANIMAL; NUCLEOSIDES; RATS; RATS, WISTAR; SERUM ALBUMIN; VIDARABINE;

EID: 0036228266     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.2.638     Document Type: Article

References (24)

1. Introduction to the biochemistry of D-arabinosyl nucleosides
2. Enhanced liver blood concentrations of adenine arabinoside accomplished by lactosaminated poly-L-lysine coupling: Implications for regional chemotherapy of hepatic micrometastases
3. Floxuridine coupling with lactosaminated human albumin to increase the drug efficacy on liver micrometastases
4. 3H]thymidine incorporation into DNA of rat regenerating liver by 2′,2′-difluorodeoxycytidine coupled to lactosaminated poly-L-lyslne
5. Regional chemotherapy of neoplastic diseases
6. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro 2′-deoxyuridine and 5-fluorouracil
7. Coupling of antiviral nucleoside analogs to lactosaminated human albumin by using the imidazolides of their phosphoric esters
8. Coupling to lactosaminated poly-L-lysine reduces the toxic effects of ribavirin on red blood cells
9. Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor
10. Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin
11. Distribution of a conjugate of 9-β-D-arabinofuranosyladenine 5′-monophosphate (ara-AMP) with lactosaminated albumin in parenchymal and sinusoidal cells of rat liver
12. The vascularization of liver metastases. Histological investigation of gelatin-injected liver specimens with special regard to the vascularization of micrometastases
13. Adjuvant chemotherapy for resectable rectal and colonic cancer
14. Protein labeling by reductive alkylation
15. High-pressure liquid chromatographic methods for determining arabinosyladenine-5′-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine
16. Colorectal cancer
17. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines
18. Effect of liver diseases on pharmacokinetic and toxicity of 9-β-D-arabinofuranosyladenine-5-phosphate
19. Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism
20. Metabolism and disposition of gemcitabine, an oncolytic deoxycytidine analog, in mice, rats, and dogs
21. Adenine arabinoside monophosphate coupled to lactosaminated albumin, administered for 4 weeks to patients with chronic type B hepatitis, decreased viremia without producing significant side effects
22. Steady-state non-linear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients
23. Effect of reductive lactosamination on the hepatic uptake of bovine ribonuclease A dimer
24. Efficacy and safety of L-HSA-ara-AMP in chronic hepatitis B patients non responder to interferon therapy: A randomized clinical trial